Screening Prostate Cancer with Blood and Urine Tests
Experts urologists, David Albala, MD and Judd W. Moul, MD, compare the utility of a variety of blood and urine tests for screening and diagnosing prostate cancer.
Experts urologists, David Albala, MD and Judd W. Moul, MD, compare the utility of a variety of blood and urine tests for screening and diagnosing prostate cancer.
The AssureMDx test demonstrated an area under the curve of 0.80 in detecting urinary tract recurrences in MIBC.
“As most of us know, 1 in 8 couples undergo issues pertaining to fertility, and in about half of those cases, there is a male…
“These results are encouraging and suggest that circulating biomarkers may be useful in guiding the use of radium-223 therapy,” says David T. Miyamoto, MD, PhD.
“We must do more to help surgeons prepare for the impact of adverse events before they happen,” says Kevin Turner MA DM FRCS(Urol).
In the intervention group, the HRQOL score changed by 23.9 points between baseline and week 13, from 18.4 to 29.5.
Comprehensive insights on ARPIs (androgen receptor pathway inhibitors) for the treatment of prostate cancer, highlighting what influences treatment decisions and safety profiles of the available…
Overall, participating pathologists felt that there is potential to increase diagnostic efficiency by using Galen Prostate in a clinical setting.
“One notable finding was that veterans may not have access to the same quality of prostate cancer care as the US general population,” says Olubiyi…
Treatment with SBRT showed a minimal effect on prostate cancer-specific HRQL measures in regard to urinary incontinence domain scores, urinary irritative/obstructive domain scores, and bowel…
“I think the long and short of it is we know tibial nerve stimulation works, we’re just trying to identify what’s the best way by…